Full-Time
Data Quality Engineer
Posted on 7/25/2025
Pattern Bioscience
51-200 employees
AI-driven rapid bacterial ID and AST
No salary listed
Pune, Maharashtra, India
Hybrid
Hybrid position.
 QA & Testing (1) |
|---|
- Should be expert in Requirement analysis, Test Scenario and Test Case writing, Producing Test Artifacts, Cross Team Collaboration, Eye for details.
- Should have experience of testing SOAP or REST requests using either SOAP UI or POSTMAN
- Should have basic moderate-level knowledge of SQL. Should be able to construct moderate to complex queries to fetch data.
- Should be well versed with Agile and ceremonies that are followed under it.
- 4-7 years of relevant technical experience in a Quality Assurance role.
- Strong knowledge of Testing Concepts, Defect Management, Test Case writing and Test Scenarios identifications.
- Strong knowledge of software testing life cycle(STLC) and software development life cycle (SDLC).
- Comprehensive knowledge of quality assurance methodologies.
- Excellent in Functional and Web-Based Testing
- Exposure to Automation Testing, API testing. Ability to write, Implement and Maintain the Test Scripts.
- Experience with creating and maintaining automation scripts with any of the automation tools.
- Participate as an active and core member of the Scrum team to ensure quality is built into products and take exposure to Agile Development Methodology.
- Participates in Sprint planning and collaborates with the Product Management team.
- Exposure and hands on experience with tools like Functional Automation (UI) Tool, API Automation tools.
- Ability to understand Quality standards and metrics for the product. Should be able to derive corrective action items for the self.
- Create Test cases, Test scenarios, and product documents based on software requirements and technical specifications, and appropriately prioritize testing tasks and test cases.
- Participate in Bug triaging and measures to prevent them.
- Be a SME for the Product
- Ensuring participation in quality improvement tools like Unit Test, RCA Addition etc.
- Communication and maintaining cordial relationships with the development team and US counterpart for delivering quality products.
- Promoting solution-oriented and congruent approach
- CSTE/CSQA/ISTQB Foundation Level certification will carry an edge.
- Good to have Knowledge of public cloud environments like AWS, Azure, and GCP
- Good Database Knowledge, writing, and executing the basic queries.
Pattern Bioscience develops rapid clinical diagnostics that identify bacterial infections and determine antibiotic resistance. Its system uses single-cell analysis with AI pattern recognition to deliver definitive ID/AST results in about four hours. The product suite includes diagnostic devices, consumables, service contracts, and software for AI analysis. By speeding and improving accuracy, Pattern Bioscience aims to help hospitals reduce inappropriate antibiotic use and combat antibiotic resistance.
Company Size
51-200
Company Stage
Series D
Total Funding
$91.6M
Headquarters
Austin, Texas
Founded
2016
Simplify's Take
What believers are saying
- $43M Series D funding from AMR Action Fund supports FDA 510(k) submission.
- $40.9M BARDA contract accelerates pneumonia and bacteremia panel development.
- Over 1,000 samples enrolled in multi-center trial for Q3 regulatory push.
What critics are saying
- Accelerate Diagnostics' PhenoVue captures market with FDA-cleared 3-hour AST.
- BioFire's FilmArray dominates ICU syndromic testing, sidelining single-pathogen focus.
- Clinical trial failure by mid-2026 exhausts Series D runway, halting launch.
What makes Pattern Bioscience unique
- Digital CultureTM enables culture-free phenotypic ID/AST in four hours.
- Single-cell analysis captures all resistance mechanisms unlike genotypic tests.
- Pneumonia ID/AST Panel targets critically ill patients with FDA Breakthrough Designation.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
Paid Holidays
401(k) Company Match
401(k) Retirement Plan
Health Savings Account/Flexible Spending Account
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↑ 2%2 year growth
↓ -1%Pattern Bioscience has raised $43 million in Series D funding, led by AMR Action Fund, Illumina Ventures, and Omnimed Capital. The funds will support a US multi-center clinical trial and regulatory submission for their Pneumonia ID/AST Panel, which has FDA Breakthrough Device Designation and is backed by a BARDA contract worth up to $40.9 million. Latham & Watkins LLP represented Pattern Bioscience in the transaction.
To quickly develop effective treatments for drug-resistant bacterial infections, Pattern is a leader in the application of single-cell microbiology.
Pattern Bioscience secures $28.7 million in Series C financing to accelerate development of first-of-its-kind infectious disease diagnostic platform
Pattern Bioscience, an Austin, TX-based company which specializes in rapid diagnosis and antibiotic susceptibility testing (AST) for bacterial infections, raised $28.7M in Series C funding.
Including the Series C round, Pattern has now raised $68 million to date, the company said in a statement.